Function of novel proteins encoded in non-canonical open reading frames
非规范开放阅读框编码的新型蛋白质的功能
基本信息
- 批准号:RGPIN-2021-03723
- 负责人:
- 金额:$ 2.7万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Proteins are key players in basically all cellular processes, where they exert a plethora of functions (e.g. catalysis of chemical reactions, transport of molecules). Understanding these functions informs us on the way our cells, organs and bodies work. For decades, it was thought that only one protein was encoded per eukaryotic gene. However, many studies in the past few years have challenged that view, and it is now evident that many genes actually encode multiple proteins. These previously unknown and ignored novel proteins, which are different from well-known protein isoforms, are called alternative proteins and are expressed in our cells in parallel to those already identified (called reference proteins), greatly expanding the protein repertoire. Despite the characterization of a small number of alternative proteins which revealed important biological functions, only a few research groups worldwide consider their existence in their work. Given their recent discovery, alternative proteins remain largely understudied, and are absent from commonly used functional genomics tools. The long-term objective of my research program is to elucidate the molecular, cellular, and organismal functions of alternative proteins, by studying specific examples (candidate approach) and using functional genomics (genome-wide approach). In the present Discovery proposal, we will focus on the following short-term objectives: 1. Determine the molecular, cellular and organismal function of SLC35A4, a gene encoding two proteins, including a strikingly abundant but uncharacterized alternative protein with possible ties to myelin, a nervous system component needed for transit of information. This will be achieved using cultured cells (including human induced pluripotent stem cells) and mouse models, coupled to biochemical, cell biology and multi-omics methods. 2. Create functional genomics tools for genome-wide CRISPR/Cas9 screening to discover the function of alternative proteins at a large scale, and use multi-omics methods to mechanistically characterize functional alternative proteins within the broader cellular landscape. Our findings on the function of our candidate gene (Objective 1) will provide the first deep characterization of this abundant alternative proteins in vertebrates. The cellular and mouse models created will be of interest for other groups to study this dual coding gene (for ex. in the myelination field). Objective 1 will exemplify the necessity of studying both alternative and reference proteins to fully understand the functions of our genes. In addition Objective 2 will significantly accelerate the researchers' ability to study the function of alternative proteins at a large scale. These novel and open functional genomics tools that integrate alternative proteins will significantly help advancing our knowledge of the contribution of alternative proteins to the function of our genes, and will place Canada at the forefront of this new field.
Proteins are key players in basically all cellular processes, where they exert a plethora of functions (e.g. catalysis of chemical reactions, transport of molecules). Understanding these functions informs us on the way our cells, organs and bodies work. For decades, it was thought that only one protein was encoded per eukaryotic gene. However, many studies in the past few years have challenged that view, and it is now evident that many genes actually encode multiple proteins. These previously unknown and ignored novel proteins, which are different from well-known protein isoforms, are called alternative proteins and are expressed in our cells in parallel to those already identified (called reference proteins), greatly expanding the protein repertoire. Despite the characterization of a small number of alternative proteins which revealed important biological functions, only a few research groups worldwide consider their existence in their work. Given their recent discovery, alternative proteins remain largely understudied, and are absent from commonly used functional genomics tools. The long-term objective of my research program is to elucidate the molecular, cellular, and organismal functions of alternative proteins, by studying specific examples (candidate approach) and using functional genomics (genome-wide approach). In the present Discovery proposal, we will focus on the following short-term objectives: 1. Determine the molecular, cellular and organismal function of SLC35A4, a gene encoding two proteins, including a strikingly abundant but uncharacterized alternative protein with possible ties to myelin, a nervous system component needed for transit of information. This will be achieved using cultured cells (including human induced pluripotent stem cells) and mouse models, coupled to biochemical, cell biology and multi-omics methods. 2. Create functional genomics tools for genome-wide CRISPR/Cas9 screening to discover the function of alternative proteins at a large scale, and use multi-omics methods to mechanistically characterize functional alternative proteins within the broader cellular landscape. Our findings on the function of our candidate gene (Objective 1) will provide the first deep characterization of this abundant alternative proteins in vertebrates. The cellular and mouse models created will be of interest for other groups to study this dual coding gene (for ex. in the myelination field). Objective 1 will exemplify the necessity of studying both alternative and reference proteins to fully understand the functions of our genes. In addition Objective 2 will significantly accelerate the researchers' ability to study the function of alternative proteins at a large scale. These novel and open functional genomics tools that integrate alternative proteins will significantly help advancing our knowledge of the contribution of alternative proteins to the function of our genes, and will place Canada at the forefront of this new field.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vanderperre, Benoît其他文献
Vanderperre, Benoît的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vanderperre, Benoît', 18)}}的其他基金
Function of novel proteins encoded in non-canonical open reading frames
非规范开放阅读框编码的新型蛋白质的功能
- 批准号:
RGPAS-2021-00005 - 财政年份:2022
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
Function of novel proteins encoded in non-canonical open reading frames
非规范开放阅读框编码的新型蛋白质的功能
- 批准号:
RGPAS-2021-00005 - 财政年份:2021
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
Function of novel proteins encoded in non-canonical open reading frames
非规范开放阅读框编码的新型蛋白质的功能
- 批准号:
RGPIN-2021-03723 - 财政年份:2021
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Grants Program - Individual
Function of novel proteins encoded in non-canonical open reading frames
非规范开放阅读框编码的新型蛋白质的功能
- 批准号:
DGECR-2021-00199 - 财政年份:2021
- 资助金额:
$ 2.7万 - 项目类别:
Discovery Launch Supplement
相似国自然基金
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
- 批准号:82304677
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
- 批准号:82070530
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
- 批准号:32002421
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
- 批准号:31902347
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
- 批准号:
10749672 - 财政年份:2024
- 资助金额:
$ 2.7万 - 项目类别:
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
- 批准号:
10751760 - 财政年份:2024
- 资助金额:
$ 2.7万 - 项目类别:
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别:
Function, regulation, and conservation of hypoxia-induced glycolysis condensates
缺氧诱导的糖酵解缩合物的功能、调节和保存
- 批准号:
10552295 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别:
Regulation of microglial function by blood-borne factors
血源性因子对小胶质细胞功能的调节
- 批准号:
10679408 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别:
Investigating the Formation and Function of Subgenomic Flavivirus RNAs During Flavivirus Infection of the Mosquito Vector
研究蚊子载体黄病毒感染过程中亚基因组黄病毒 RNA 的形成和功能
- 批准号:
10677398 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别:
Function and regulation of heterotrimeric G proteins in ciliogenesis and pathobiology of neurodevelopmental disorders
异源三聚体 G 蛋白在纤毛发生和神经发育障碍病理学中的功能和调节
- 批准号:
10651317 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别:
Structure and Function of the SHOC2 Holophosphatase Complex in RAS-driven Cancer
SHOC2 全磷酸酶复合物在 RAS 驱动的癌症中的结构和功能
- 批准号:
10662750 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别:
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
通过描绘基因 3 端 DNA 甲基化功能,全面了解癌症的表观遗传脆弱性
- 批准号:
10765365 - 财政年份:2023
- 资助金额:
$ 2.7万 - 项目类别: